Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 110.22 USD 1.68% Market Closed
Market Cap: 21.9B USD
Have any thoughts about
Zimmer Biomet Holdings Inc?
Write Note

Operating Margin
Zimmer Biomet Holdings Inc

20.4%
Current
18%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.4%
=
Operating Profit
1.6B
/
Revenue
7.6B

Operating Margin Across Competitors

Country US
Market Cap 22B USD
Operating Margin
20%
Country US
Market Cap 204.9B USD
Operating Margin
17%
Country US
Market Cap 195.2B USD
Operating Margin
26%
Country US
Market Cap 146.7B USD
Operating Margin
22%
Country US
Market Cap 132.6B USD
Operating Margin
18%
Country IE
Market Cap 110.6B USD
Operating Margin
19%
Country US
Market Cap 64.7B USD
Operating Margin
14%
Country DE
Market Cap 55.6B EUR
Operating Margin
12%
Country CN
Market Cap 319.2B CNY
Operating Margin
37%
Country US
Market Cap 41.6B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Zimmer Biomet Holdings Inc
Glance View

Market Cap
22B USD
Industry
Health Care

Zimmer Biomet Holdings Inc. is a leading global medical device company renowned for its innovative solutions in the musculoskeletal health sector. Founded in 1927 and headquartered in Warsaw, Indiana, the company specializes in orthopedic implants, including those used in joint reconstruction and spinal surgery, as well as dental and neuromuscular devices. With a commitment to enhancing the quality of life for patients worldwide, Zimmer Biomet leverages cutting-edge technology and extensive research to develop products that cater to an aging population and a growing demand for minimally invasive surgical options. As the healthcare landscape evolves, Zimmer Biomet’s adaptable business strategy and focus on strategic partnerships position it favorably to capture new market opportunities and drive future growth. For investors, Zimmer Biomet represents a compelling choice within the healthcare sector due to its strong market presence and consistent revenue generation. The company operates in a resilient industry characterized by ongoing technological advancements and a steady demand for orthopedic procedures driven by demographic trends. Zimmer Biomet has strategically streamlined its operations, enhancing operational efficiencies and reducing costs, which are promising signs of financial health. With a robust pipeline of innovative products and a focus on expanding its global footprint, Zimmer Biomet is well-equipped to navigate the complexities of the healthcare market and deliver sustainable value to its shareholders over the long term.

ZBH Intrinsic Value
153.21 USD
Undervaluation 28%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.4%
=
Operating Profit
1.6B
/
Revenue
7.6B
What is the Operating Margin of Zimmer Biomet Holdings Inc?

Based on Zimmer Biomet Holdings Inc's most recent financial statements, the company has Operating Margin of 20.4%.